108 related articles for article (PubMed ID: 18815925)
1. Hereditary bladder cancer.
Kiemeney LA
Scand J Urol Nephrol Suppl; 2008 Sep; (218):110-5. PubMed ID: 18815925
[TBL] [Abstract][Full Text] [Related]
2. Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression.
Malats N
Scand J Urol Nephrol Suppl; 2008 Sep; (218):131-40. PubMed ID: 18815927
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association studies in bladder cancer: first results and potential relevance.
Kiemeney LA; Grotenhuis AJ; Vermeulen SH; Wu X
Curr Opin Urol; 2009 Sep; 19(5):540-6. PubMed ID: 19553824
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and genetic susceptibility to bladder cancer.
Wu X; Ros MM; Gu J; Kiemeney L
BJU Int; 2008 Nov; 102(9 Pt B):1207-15. PubMed ID: 19035883
[TBL] [Abstract][Full Text] [Related]
5. Bladder cancer subtypes defined by genomic alterations.
Knowles MA
Scand J Urol Nephrol Suppl; 2008 Sep; (218):116-30. PubMed ID: 18815926
[TBL] [Abstract][Full Text] [Related]
6. General lessons from large-scale studies to identify human cancer predisposition genes.
Cazier JB; Tomlinson I
J Pathol; 2010 Jan; 220(2):255-62. PubMed ID: 19927315
[TBL] [Abstract][Full Text] [Related]
7. Genitourinary cancer predisposition syndromes.
Gallagher DJ; Feifer A; Coleman JA
Hematol Oncol Clin North Am; 2010 Oct; 24(5):861-83. PubMed ID: 20816578
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications.
Wu X; Hildebrandt MA; Chang DW
Cancer Metastasis Rev; 2009 Dec; 28(3-4):269-80. PubMed ID: 20016998
[TBL] [Abstract][Full Text] [Related]
9. [Study of bladder cancer gene and relevant molecular biology should be strengthened].
Li CL; Han SJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):793-4. PubMed ID: 17565855
[No Abstract] [Full Text] [Related]
10. Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions.
Horikawa Y; Gu J; Wu X
Curr Opin Urol; 2008 Sep; 18(5):493-8. PubMed ID: 18670273
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
[TBL] [Abstract][Full Text] [Related]
12. Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.
Chang CH; Wang RF; Tsai RY; Wu HC; Wang CH; Tsai CW; Chang CL; Tsou YA; Liu CS; Bau DT
Anticancer Res; 2009 Oct; 29(10):3903-7. PubMed ID: 19846926
[TBL] [Abstract][Full Text] [Related]
13. 192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer.
Oztürk O; Kağnici OF; Oztürk T; Durak H; Tüzüner BM; Kisakesen HI; Cakalir C; Isbir T
Anticancer Res; 2009 Oct; 29(10):4041-6. PubMed ID: 19846948
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population.
Rouissi K; Ouerhani S; Oliveira E; Marrakchi R; Cherni L; Ben Othman F; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; Prata MJ; Benammar Elgaaied A
Cancer Genet Cytogenet; 2009 Nov; 195(1):43-53. PubMed ID: 19837268
[TBL] [Abstract][Full Text] [Related]
15. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
Gangwar R; Mandhani A; Mittal RD
Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide linkage scan for bladder exstrophy-epispadias complex.
Ludwig M; Rüschendorf F; Saar K; Hübner N; Siekmann L; Boyadjiev SA; Reutter H
Birth Defects Res A Clin Mol Teratol; 2009 Feb; 85(2):174-8. PubMed ID: 19086019
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of DNA repair genes in bladder cancer.
Kiltie AE
Methods Mol Biol; 2009; 472():281-306. PubMed ID: 19107438
[TBL] [Abstract][Full Text] [Related]
18. Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy.
Ahirwar DK; Mandhani A; Dharaskar A; Kesarwani P; Mittal RD
BJU Int; 2009 Sep; 104(6):867-73. PubMed ID: 19338536
[TBL] [Abstract][Full Text] [Related]
19. Improving strategies for detecting genetic patterns of disease susceptibility in association studies.
Calle ML; Urrea V; Vellalta G; Malats N; Steen KV
Stat Med; 2008 Dec; 27(30):6532-46. PubMed ID: 18837071
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
